SUMMARY Cold insoluble globulin (CIG) is a normal glycoprotein of human serum and plasma. The physiological significance of this protein is unknown, but it shows a temperature-dependent relation to fibrinogen and fibrin. It is possible that it represents a substrate for activated fibrinstabilising factor in the polymerisation of fibrin. CIG is found on the surface of fibroblasts. In the present study CIG was estimated in citrated plasma in 115 patients with rheumatic diseases. Increased amounts were found in patients with systemic lupus erythematosus, secondary amyloidosis in classical and definite rheumatoid arthritis, and in male patients with juvenile rheumatoid arthritis.
Cold insoluble globulin (CIG) is a normal glycoprotein of human serum and plasma (Blomback and Blombaick, 1956; Mosesson and Umfleet, 1970) . In gel electrophoresis it moves between the alpha2-and the beta1-globulin bands (Laurell, 1972) . It consists of at least 2 polypeptide chains bound together with disulphide bridges and with a molecular weight of about 440 000 daltons (Mosesson et al., 1975; Fyrand and Solum, 1976b) . CIG is found on the surface of fibroblasts and glial cells (Ruoslahti and Vaheri, 1975) . It represents the main non-clottable protein of heparin precipitable fraction (Fyrand and Solum, 1976b) . The physiological significance of CIG is unknown. Only a few clinical studies on CIG have been published, most of them reporting a fairly constant plasma level of this protein (Aronsen et al., 1972; Johansson et al., 1972; HaIller and Laurell, 1972; Fyrand, 1977 Association (Bennett and Burch, 1967) .
Accepted for publication December 12, 1977 At the time of investigation, all patients were receiving various medications (analgesics, antiinflammatory and cytostatic agents). Electroimmunoassay was performed for the estimation of the levels of CIG in plasma. The reference and the control groups for this assay are described elsewhere (Fyrand and Solum, 1976a) .
Methods
The production of citrated plasma and the procedure of electroimmunoassay is described elsewhere (Fyrand and Solum, 1976a Significantly raised levels of CIG were found in the male group of juvenile rheumatoid arthritis (P < 0*025) in contrast to the corresponding female group. An increase was also found in female patients with secondary amyloidosis in rheumatoid arthritis (P < 0.001) and in females with systemic lupus erythematosus (SLE) (P <0 01). The corresponding male groups were too small for statistical evaluation, but the single male patient in each group demonstrated a raised level of CIG (197 U/ml and 140 U/mI, respectively). Plasma CIG levels in ankylosing spondylitis, psoriatic arthritis, and progressive systemic sclerosis did not differ significantly from the control groups.
Discussion
Concentrations of CIG in healthy persons is dependent upon age and sex (Fyrand and Solum, 1976a) . Women below 50 years demonstrate significantly lower levels of CIG compared with women over 50 (P < 0.01) and with all male groups (P < 0 02). In men increased concentrations are found in higher age groups but the difference is not statistically significant. In women over 50 plasma CIG levels are not different from those of the corresponding male group (Fyrand and Solum, 1976a) .
CIG is present on the surface of fibroblasts (Ruoslahti and Vaheri, 1975) . When the cells are cultured in vitro, CIG is found in the medium. When these fibroblasts are transformed by addition of Rous' sarcoma virus, CIG disappears from the surface (Vaheri and Ruoslahti, 1974) . It may be that fibroblasts represent the source of CIG in blood (Ruoslathi and Vaheri, 1975) . Studies on CIG in diseases affecting connective tissue may therefore be of importance, as indicated by increased amounts of CIG in plasma reported in this study. As to increased amounts of plasma CIG in secondary amyloidosis, recent reports demonstrate that fibroblast may be responsible for the production of amyloid (Natvig et al., 1977; Runne and Orefanos, 1977) .
Lower CIG values in the female group of juvenile rheumatoid arthritis may be explained by a higher age level of the patients in this group compared with the male group, and may therefore represent a higher incidence of 'burned out' cases. Levels of CIG in plasma are considerably lower in newborns, but have not been reported in healthy children, and this may also influence the statistical significance of patients with juvenile rheumatoid arthritis. As there Studies on cold insoluble globulin 349 is a tendency towards lower levels of CIG in plasma in lower age groups (Fyrand and Solum, 1976a/b; Ganrot, 1972) , adequate control groups for juvenile patients would probably give lower P values than those indicated in this study in juvenile rheumatoid arthritis.
Further studies on CIG in plasma in these subgroups (SLE, juvenile rheumatoid arthritis, secondary amyloidosis) compared with corresponding age and sex control groups should be undertaken. 
